"Blood Glucose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glucose in blood.
Descriptor ID |
D001786
|
MeSH Number(s) |
D09.947.875.359.448.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Blood Glucose".
Below are MeSH descriptors whose meaning is more specific than "Blood Glucose".
This graph shows the total number of publications written about "Blood Glucose" by people in this website by year, and whether "Blood Glucose" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 5 | 6 |
1996 | 0 | 11 | 11 |
1997 | 4 | 4 | 8 |
1998 | 3 | 6 | 9 |
1999 | 4 | 8 | 12 |
2000 | 2 | 4 | 6 |
2001 | 3 | 9 | 12 |
2002 | 8 | 14 | 22 |
2003 | 5 | 9 | 14 |
2004 | 7 | 15 | 22 |
2005 | 5 | 17 | 22 |
2006 | 6 | 15 | 21 |
2007 | 2 | 14 | 16 |
2008 | 5 | 16 | 21 |
2009 | 7 | 25 | 32 |
2010 | 10 | 22 | 32 |
2011 | 8 | 30 | 38 |
2012 | 8 | 23 | 31 |
2013 | 6 | 25 | 31 |
2014 | 6 | 20 | 26 |
2015 | 12 | 25 | 37 |
2016 | 4 | 21 | 25 |
2017 | 7 | 21 | 28 |
2018 | 8 | 18 | 26 |
2019 | 7 | 14 | 21 |
2020 | 6 | 26 | 32 |
2021 | 7 | 21 | 28 |
2022 | 4 | 24 | 28 |
2023 | 2 | 17 | 19 |
2024 | 6 | 16 | 22 |
2025 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Blood Glucose" by people in Profiles.
-
Differential Treatment Effects on ?-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care. 2025 Apr 01; 48(4):623-631.
-
Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development. Diabetologia. 2025 May; 68(5):930-939.
-
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring. Horm Res Paediatr. 2024; 97(6):615-635.
-
A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts. Diabetes Technol Ther. 2025 Mar; 27(3):179-186.
-
The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes. Lipids Health Dis. 2024 Dec 23; 23(1):416.
-
The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes: a systematic review and meta-analysis of randomised controlled trials. Int J Behav Nutr Phys Act. 2024 Dec 23; 21(1):145.
-
Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial. Diabetologia. 2025 Mar; 68(3):676-687.
-
Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance. J Endocrinol Invest. 2025 Mar; 48(3):765-775.
-
Age and sex mark clinical differences in the presentation of pediatric type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2025 Jan 29; 38(1):22-28.
-
Real-world treatment patterns in drug na?ve type 2 diabetes population: Initial combination therapy vs. sequential step-therapy. J Am Pharm Assoc (2003). 2025 Jan-Feb; 65(1):102295.